Form D · Pharmaceuticals
Accretion Therapeutics, Inc.
Lincolnshire, IL · CIK 0002109293
Offering snapshot reported Feb 17, 2026 · SEC filing
- Reported sold
- $750K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $750K Reported outside-investor minimum
- First sale
- Feb 4, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 17, 2026 | Initial | $750,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-573655
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed Feb 17, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Holecek | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
416 Old Mill Cir
Lincolnshire, IL, 60069
Phone: 8473233236
Lincolnshire, IL, 60069
Phone: 8473233236